News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Patent Application Published for PharmAla Biotech’s MDMA Analogs
Pharmala Biotech Holdings
PharmaDrug Collaborates with PharmaTher for Development of DMT Transdermal Patch
Pharmadrug Inc.
Pharmather
Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
Algernon Pharmaceuticals
Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC
Lobe Sciences
Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction
Nirvana Life Sciences
Wellbeing Provides Bi-Weekly Default Status Report
Wellbeing Digital Sciences
Algernon NeuroScience Provides Update on Phase 1 DMT Clinical Study, Drug Found Safe to Proceed to Next Phase
Algernon Pharmaceuticals
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US
Clearmind Medicine
Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
Nova Mentis Life Science
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
Wellbeing Digital Sciences
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results
Reunion Neuroscience
PharmAla Biotech Closes Purchase Order With Emyria Ltd., Completes Filing of “LaNeo” Trademark in Australia
Pharmala Biotech Holdings
Cognetivity Neurosciences Releases Latest Version of AI-powered Brain Health Assessment Platform
Cognetivity Neurosciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.